These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7266702)

  • 1. The nephrotic syndrome and ischaemic heart disease.
    Mallick NP; Short CD
    Nephron; 1981; 27(2):54-7. PubMed ID: 7266702
    [No Abstract]   [Full Text] [Related]  

  • 2. Dyslipoproteinaemia in Nigerians with the nephrotic syndrome (an increased risk for ischaemic heart disease?).
    Erasmus RT; Arije A; Uyot C
    Cent Afr J Med; 1990 Aug; 36(8):195-8. PubMed ID: 2282650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and lipoproteins as risk indicators for coronary heart disease (a study on male patients with defined vessel findings).
    Herrmann W; Schütz C; Hanf S; Lindhofer HG; Schmidt H; Strauss HJ; Schaedel H; Oswald B
    Przegl Lek; 1989; 46(7):604-10. PubMed ID: 2587789
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypercholesterolemia does not cause coronary heart disease--evidence from the nephrotic syndrome.
    Ravnskov U
    Nephron; 1994; 66(3):356-9. PubMed ID: 8031391
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL; Packard CJ
    Miner Electrolyte Metab; 1993; 19(3):115-26. PubMed ID: 8232098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid abnormalities in renal disease.
    Appel G
    Kidney Int; 1991 Jan; 39(1):169-83. PubMed ID: 2002630
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in serum lipoproteins in kidney diseases. Therapeutic possibilities].
    Walther A; Mordasini R; Riesen W
    Dtsch Med Wochenschr; 1983 Mar; 108(10):388. PubMed ID: 6337805
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in serum lipoproteins in kidney diseases. Clinical and pathogenetic aspects].
    Walther A; Mordasini R; Riesen W
    Dtsch Med Wochenschr; 1983 Mar; 108(10):385-7. PubMed ID: 6825580
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN; Tvorogova MG; Levitova EN; Krylova EA
    Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of coronary heart disease associated with combined elevation of serum triglyceride and cholesterol concentrations in the nephrotic syndrome in man.
    Alexander JH; Schapel GJ; Edwards KD
    Med J Aust; 1974 Jul; 2(4):119-22. PubMed ID: 4419153
    [No Abstract]   [Full Text] [Related]  

  • 11. Apolipoprotein E phenotype and hyperlipoproteinemia in nephrotic syndrome.
    Lerique B; Moulin B; Delpéro C; Purgus R; Olmer M; Boyer J
    Clin Chem; 1994 May; 40(5):849-50. PubMed ID: 8174269
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperlipoproteinemia as a factor in the progression of glomerulonephritis with nephrotic syndrome].
    Smirnov AV; Sazonets GI; Rakitianskaia IA; Travkina ES
    Ter Arkh; 1992; 64(11):45-8. PubMed ID: 1293843
    [No Abstract]   [Full Text] [Related]  

  • 13. High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.
    Ariëns RA; Moia M; Rivolta E; Ponticelli C; Mannucci PM
    Thromb Haemost; 1999 Sep; 82(3):1020-3. PubMed ID: 10494757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Idiopathic nephrotic syndrome. II. Humoral disorders and complications].
    Klinger M; Szewczyk Z
    Przegl Lek; 1989; 46(8):659-63. PubMed ID: 2594999
    [No Abstract]   [Full Text] [Related]  

  • 15. Status of the coronary arteries in the nephrotic syndrome. Analysis of 20 necropsy patients aged 15 to 35 years to determine if coronary atherosclerosis is accelerated.
    Curry RC; Roberts WC
    Am J Med; 1977 Aug; 63(2):183-92. PubMed ID: 888841
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.
    Rössner S
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S201-5. PubMed ID: 6177957
    [No Abstract]   [Full Text] [Related]  

  • 17. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN
    Miner Electrolyte Metab; 1993; 19(3):127-36. PubMed ID: 8232099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in serum lipoproteins in kidney diseases].
    Mordasini R; Riesen W
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1335-40. PubMed ID: 6755693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum lipoprotein level and coronary disease].
    Saprygin DB; Bielawski WI; Guslienko LS
    Przegl Lek; 1989; 46(7):599-603. PubMed ID: 2587788
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of marked hyperlipoprotein(a)emia associated with nephrotic syndrome and advanced atherosclerosis.
    Kuge Y; Nozaki S; Kitagawa A; Inoue T; Otsuka H; Ito Y
    J Atheroscler Thromb; 2004; 11(5):293-8. PubMed ID: 15557712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.